COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,186 Articles (22,197 medRxiv, 7,989 bioRxiv)

Most recent first Previous |  Page 1311: Articles 13101-13110  | Next

Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology
Kishimoto, T., Kinoshita, S., Bun, S., Sato, Y., Kitazawa, M., Kikuchi, T., Sado, M., Takamiya, A., Mimura, M., Nakamae, T., Abe, Y., Kanazawa, T., Kawabata, Y., Tomita, H., Abe, K., Hishimoto, A., Asami, T., Suda, A., Watanabe, Y., Amagai, T., Sakuma, K., Kida, H., Funayama, M., Kimura, H., Sato, A., Fujiwara, S., Nagao, K., Sugiyama, N., Takamiya, M., Kodama, H., Azekawa, T.
10.1101/2021.06.23.21259366 — Posted: 2021-06-29
Tracking SARS-CoV-2 in rivers as a tool for epidemiological surveillance
Maidana-Kulesza, M. N., Poma, H. R., Sanguino-Jorquera, D. G., Reyes, S. I., Said-Adamo, M. d. M., Remis, M. M., Gutierrez-Cacciabue, D., Cristobal, H. A., Cruz, M. C., Gonzalez, M. A., Rajal, V. B.
10.1101/2021.06.17.21259122 — Posted: 2021-06-29
Accuracy of telephone triage for predicting adverse outcome in suspected COVID-19: An observational cohort study
Marincowitz, C., Stone, T., Bath, P., Richard Campbell, R., Turner, J., Hussein, M., Pilbery, R., Thomas, B., Sutton, L., Bell, F., Biggs, K., Hopfgartner, F., Mazumdar, S., Petrie, J., Goodacre, S.
10.1101/2021.06.24.21259441 — Posted: 2021-06-29
DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19
Bagno, F. F., Sergio, S. A. R., Figueiredo, M. M., Godoi, L. C., Andrade, L. A. F., Salazar, N. C., Soares, C. P., Aguiar, A., Almeida, F. J., da Silva, E. D., Ferreira, A. G. P., Durigon, E. L., Gazzinelli, R. T., Teixeira, S. M. R., Fernandes, A. P. S. M., da Fonseca, F. G.
10.1101/2021.06.23.21259392 — Posted: 2021-06-29
Characterizing Long COVID: Deep Phenotype of a Complex Condition
Deer, R. R., Rock, M. A., Vasilevsky, N., Carmody, L. C., Rando, H. M., Anzalone, A. J., Callahan, T. J., Bramante, C. T., Chute, C. G., Greene, C. S., Gagnier, J. J., Chu, H., Koraishy, F. M., Liang, C., Liu, F., Madlock-Brown, C. R., Mazzotti, D. R., McNair, D. S., Parker, A. M., Coleman, B. D., Davis, H. E., Perry, M. A., Reese, J. T., Saltz, J. H., Solomonides, A. E., Sule, A. A., Stein, G. S., Kohler, S., Monteith, T. S., Madhira, V., Kimble, W. D., Kavuluru, R., Hillegass, W. B., Chan, L. E., Byrd, J. B., Boudreau, E. A., Liu, H., McMurry, J. A., Pfaff, E. R., Matentzoglu, N., Relevo, R., Moffitt, R. A., Schuff, R. A., Solway, J., Spratt, H., Bergquist, T., Bennett, T. D., Basson, M. D., Topaloglu, U., Wang, L., Haendel, M. A., Robinson, P. N.
10.1101/2021.06.23.21259416 — Posted: 2021-06-29
Sequencing SARS-CoV-2 Genomes from Saliva
Alpert, T., Vogels, C. B. F., Breban, M. I., Petrone, M., Yale IMPACT Research Team, , Wyllie, A. L., Grubaugh, N., Fauver, J. R.
10.1101/2021.06.21.21259289 — Posted: 2021-06-29
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo
Chiem, K., Vasquez, D. M., Silvas, J., Park, J.-G., Piepenbrink, M., Sourimant, J., Lin, M. J., Greninger, A. L., Plemper, R. K., Torrelles, J. B., Walter, M. R., de la Torre, J. C., Kobie, J., Martinez-Sobrido, L.
10.1101/2021.06.28.450214 — Posted: 2021-06-28
Enhanced fitness of SARS-CoV-2 variant of concern B.1.1.7, but not B.1.351, in animal models
Ulrich, L., Halwe, N. J., Taddeo, A., Ebert, N., Schön, J., Devisme, C., Trüeb, B. S., Hoffmann, B., Wider, M., Bekliz, M., Essaidi-Laziosi, M., Schmidt, M. L., Niemeyer, D., Corman, V. M., Kraft, A., Godel, A., Laloli, L., Kelly, J. N., Breithaupt, A., Wylezich, C., Berenguer Veiga, I. M., Gultom, M., Adea, K., Meyer, B., Eberhardt, C., Thomann, L., Gsell-Albert, M., Labroussaa, F., Jores, J., Summerfield, A., Drosten, C., Eckerle, I. A., Dijkman, R., Hoffmann, D., Thiel, V., Beer, M., Benarafa, C.
10.1101/2021.06.28.450190 — Posted: 2021-06-28
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: everybody does their best
Fernandez Salinas, A., Piano Mortari, E., Terreri, S., Quintarelli, C., Pulvirenti, F., Di Cecca, S., Guercio, M., Milito, C., Bonanni, L., Auria, S., Romaggioli, L., Cusano, G., Albano, C., Zaffina, S., Perno, C. F., Spadaro, G., Locatelli, F., Carsetti, R., Quinti, I.
10.1101/2021.06.24.21259130 — Posted: 2021-06-28
N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replication
Stegmann, K. M., Dickmanns, A., Heinen, N., Gross, U., Goerlich, D., Pfaender, S., Dobbelstein, M.
10.1101/2021.06.28.450163 — Posted: 2021-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).